Secondary Recommendation

AL Noor Hospitals - Exciting new issue in fast growing Middle East private health care market

August 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Following the successful float of NMC Health, a Dubai-based provider of private hospital care and pharmaceutical products, in April 2012, which whizzed up from its 210p placing price to hit 340p at one point, another Middle-Eastern focused healthcare group, Al Noor Hospitals, has also been well-received by investors. Al Noor, which is the largest integrated private healthcare provider in Abu Dhabi, already boasts a terrific record with revenues increasing 34% to US$324m and net profit 58% to US$60.5m (eps 34.3p, assuming Â£1=US$1.51) in the two years to 31 December 2012. Not surprisingly, its shares, which were introduced by Deutsche Bank and Goldman Sachs in a placing at 575p, raising Â£97m for the company and Â£123m for selling s ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Ashtead - Equipment rental group enjoys succession of eps upgrades

Crest Nicholson - Forward sales 50% ahead of prior year

Al Noor Hospitals - VPSâ€ˆHealthcare and NMC could yet gatecrash agreed Mediclinic offer (December 2015)

Al Noor Hospitals - In merger talks (November 2015)

Al Noor Hospitals - Shares hit by director sale (June 2015)

Al Noor Hospitals - Shares hit new high (October 2014)

Al Noor Hospitals (June 2014)

Al Noor Hospitals (April 2014)

Al Noor Hospitals - Third acquisition post float (February 2014)

Al Noor Hospitals - Makes its first two acquisitions (December 2013)

Al Noor Hospitals - Hospitals group forecast to grow eps 88% over next three years (October 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X